Chemotherapy of Leishmaniasis
•Download as PPTX, PDF•
0 likes•100 views
Introduction to Leishmaniasis History of Leishmaniasis Clinical Description Diagnosis Life cycle of Leishmaniasis Drugs used in the treatment of Leishmaniasis List of targets indentifieed for Leishmaniasis
Report
Share
Report
Share
Recommended
Immunopharmacology & immunology Unit-1 (PC-660)
Introduction to immunopharmacology, immunomodulators, immunostimulants and Immunosuppressants
Histopathological staining techniques used in liver diseases
1. Hematoxylin & Eosin staining
2. Masson's Trichrome staining
3. Sirius Red staining
Pain Models-Screening Assay in vitro & in vivo
Concepts of Preclinical Screening- In vitro/ In vivo screening of models for Pain
Caco-2 cell permeability assay for drug absorption
Drug absorption by the human intestine
Models of intestinal absorption of pharmaceutical compounds.
Characteristics of Caco-2 cells
Permeability assessment
Cultivation of Caco-2 cell monolayers
Trans Epithelial Electrical Resistance (TEER) measurement
LY rejection
Caco-2 permeability assay procedure
Apparent permeability, Papp(cm/s) & Efflux Ratio
BIOTRANSFORMATION UNIT -1 DRUG METABOLISM (1).pptx
1. Introduction
2. Phases of metabolism
3. Phase-I Metabolism
4. Cytochrome P family
5. Phase –II Metabolism
6. First pass metabolism
7. Ante Drugs
8. Microsomal Enzymes induction
Role of metabolism in drug discovery
Significance of DMPK in drug discovery.pptx
1.Introduction
2. What is DMPK
3. Objectives/ Significance of DMPK
4. Why DMPK
5. Role of USFDA
6. ADMET/PK
7. Bioanalysis
8. Conclusion
CONTAMINANTS IN CELL CULTURE & PRECAUTIONS.pptx
1. INTRODUCTION TO CELL CULTURE
2. SOURCES & TYPES OF CONTAMINATION
3. MONITORING OF CONTAMINATION IN CELL CULTURE
4. CROSS CONTAMINATION
5. ANTIBIOTIC USE
Recommended
Immunopharmacology & immunology Unit-1 (PC-660)
Introduction to immunopharmacology, immunomodulators, immunostimulants and Immunosuppressants
Histopathological staining techniques used in liver diseases
1. Hematoxylin & Eosin staining
2. Masson's Trichrome staining
3. Sirius Red staining
Pain Models-Screening Assay in vitro & in vivo
Concepts of Preclinical Screening- In vitro/ In vivo screening of models for Pain
Caco-2 cell permeability assay for drug absorption
Drug absorption by the human intestine
Models of intestinal absorption of pharmaceutical compounds.
Characteristics of Caco-2 cells
Permeability assessment
Cultivation of Caco-2 cell monolayers
Trans Epithelial Electrical Resistance (TEER) measurement
LY rejection
Caco-2 permeability assay procedure
Apparent permeability, Papp(cm/s) & Efflux Ratio
BIOTRANSFORMATION UNIT -1 DRUG METABOLISM (1).pptx
1. Introduction
2. Phases of metabolism
3. Phase-I Metabolism
4. Cytochrome P family
5. Phase –II Metabolism
6. First pass metabolism
7. Ante Drugs
8. Microsomal Enzymes induction
Role of metabolism in drug discovery
Significance of DMPK in drug discovery.pptx
1.Introduction
2. What is DMPK
3. Objectives/ Significance of DMPK
4. Why DMPK
5. Role of USFDA
6. ADMET/PK
7. Bioanalysis
8. Conclusion
CONTAMINANTS IN CELL CULTURE & PRECAUTIONS.pptx
1. INTRODUCTION TO CELL CULTURE
2. SOURCES & TYPES OF CONTAMINATION
3. MONITORING OF CONTAMINATION IN CELL CULTURE
4. CROSS CONTAMINATION
5. ANTIBIOTIC USE
UNIT- 10 ANIMAL CELL CULTURE TECHNIQUES (3).pptx
1. History of Cell Culture
2. Introduction to cell culture
3. types of cell lines
4. culture media
5. serum in culture media
6. Applications of cell & tissue culture
7. Adherence
8. Cell line evolution
9. Passaging, revival and cryopreservation
10. cell culture laboratory layout
LABORATORY SETUP OF A CELL CULTURE LAB
1. Typical setup of a cell culture lab
2. Cell culture equipment
3. Equipment & materials required
4. Basic components of a cell culture lab
5. Aseptic work area
6. Cell culture hood
7. Clean benches
8. Incubators
9. Storage
10. Cell counter
11. Aseptic techniques
12. Sterilization
13. References
Introduction to cell culture- concepts of cell culture part-1
Introduction to Cell Culture
What is Cell Culture?
Finite vs Continuous Cell Line
Culture Conditions
Cryopreservation
Morphology of Cells in Culture
Applications of Cell Culture
PORTAL HYPERTENSION
1. Introduction & history of portal hypertension
2. Etiology & pathophysiology of portal hypertension
3. Preclinical models of portal hypertension
4. Current, potential & future therapeutic approaches
5. Future prospects
6. References
Regulatory Affairs Interview Questions .pdf
This document contains the mostly asked questions for the job interviews of drug regulatory affairs which will help the candidate ace the interview with ease
Thank me later for this :*)
Hypersensitivity reactions
1. What are hypersensitivity reactions
2. Types of hypersensitivity reactions
3. Type 1 Hypersensitivity reaction
4. Type 2 Hypersensitivity reaction
5. Type 3 Hypersensitivity reaction
6. Type 4 Hypersensitivity reaction
7. Summary
EXPERIMENTAL MODELS OF LIVER DAMAGE
1. Introduction & Pathophysiology of Liver fibrosis
2. Experimental Models of Hepatic fibrosis
3. Timeline of development of Fibrotic models
4. Surgically developed models for Fibrosis
5. Chemically Induced Models for Fibrosis
6. Diet Induced Models for Fibrosis
7. Infection based models
8. Extra points
9. Conclusion
10. References
ANTIOXIDANTS FOR HEPATIC CIRRHOSIS.pptx
1. WHAT IS HEPATIC CIRRHOSIS
2. STAGES OF HEPATIC CIRRHOSIS
3. HEPATIC CIRRHOSIS ASSOCIATED COMORBIDITIES
4. PATHOPHYSIOLOGY OF HEPATIC CIRRHOSIS
5. MOLECULAR AND CELLULAR MECHANISMS INVOLVED IN LIVER FIBROGENESIS
6. FREE RADICALS
7. HOW DO FREE RADICALS CAUSE HEPATIC FIBROSIS/ CIRRHOSIS
8. POTENTIAL THERAPEUTIC COMPOUNDS BASED ON ANTIOXIDANT PROPERTIES
INFLAMMATORY BOWEL DISEASES
1. What are IBD
2. Causes of IBD
3. Signs/ symptoms & complications of IBD
4. Crohn's disease- pathophysiology
5. Ulcerative colitis- pathophysiology
6. Preclinical models for IBD
7. DSS induced IBD
8. Terminalia chebula extracts
GENE AND CELL THERAPY FOR CVDs
1. Gene therapy
2. Principles of gene therapy
3. Viral vectors of gene therapy
4. Non- viral vectors of gene therapy
5. Molecular Targets for gene therapy in CVDs
6. General strategies for gene therapy
7. Cell therapy for CVDs
8. Barriers for gene therapy
9. Routes of administration for gene therapy
10. Clinical trials
11. Conclusion
12. References
THANK YOU
GENE THERPY & CELL BASED THERAPY FOR CNS DISORDERS
1. WHAT IS GENE THERAPY
2. PRINCIPLE OF GENE THERAPY
3. TYPES OF GENE THERAPY
4. VECTORS IN GENE DELIVERY SYSTEM
5. ROLE OF GENE THERAPY IN CNS DISORDERS
6. GENE THERAPY FOR ALZHEIMERS DISEASE
7. GENE THERAPY FOR AMYOTROPIC LATERAL SCLEROSIS
8. GENE THERAPY FOR STROKE
9. CELL THERAPY FOR CNS DISORDERS
10. CELL THERAPY STRATEGIES
11. CELL THERAPY FOR PARKINSON
12. CELL THERAPY FOR HUNTINGTONS DISEASE
13. CRISPR/CAS9
NOVEL DRUG DELIVERY SYSTEMS- A FLASHCARD
1. DRUG RELEASE PROFILE IN CDDS
2. Drug release profile graph
3. CLASSIFICATION OF CONTROLLED RELEASE SYSTEMS
4. DIFFERENCES BETWEEN MATRIX & RESERVOIR SYSTEM
5. RETARDANTS USED IN MATRIX TABLET FORMULATION
6. CLASSIFICATION OF NOVEL DRUG DELIVERY SYSTEMS
7. FORMULATION OF TRANSDERMAL DRUG DELIVERY SYSTEMS
8. CLINICALLY APPROVED LIPOSOMAL FORMULATIONS
MULTIFACETED ROLES OF AUTOPHAGY IN CANCER & NEURODEGENERATIVE DISORDERS
1. What is Autophagy
2. Overview of the mechanisms lying behind autophagy
3. Mechanism of autophagy
4. Physiological role of autophagy
5. Role of Autophagy in cancer
6. Autophagy in tumor suppression
7. Autophagy in tumor promotion
8. Role of Autophagy in neurodegenerative diseases
9. Mechanism of autophagy in neurodegenerative disorders
10. Conclusion
11. References
12. Thank You
Biotransformation
1. Introduction
2. Phase 1 metabolism- Oxidation, reduction, conjugation, hydrolysis
3. Phase 2 metabolism- glucuronidation, sulfonation, acetylation, methylation, glycination, glutathionation, ribonucleotide based metabolism
4. Summary
5. Thank you
Sulphate Conjugation & EMT pathways in cancer
1. Sulphonation metabolism- introduction, types of sulphate transferases, reactions, summary
2. EMT pathways explaining metastasis in cancer and molecular pathways
3. Thank you
The pharmacology of anti-depressants
WHAT IS DEPRESSION
ETIOLOGY OF DEPRESSION
HISTORY, EXAMINATION & EPIDEMIOLOGY OF DEPRESSION
PATHOPHYSIOLOGY
ANTI- DEPRESSANTS
MAO- INHIBITORS
TCA ANTIDEPRESSANTS
SSRI’s
SNRI’s
ATYPICAL ANTIDEPRESSANTS
NOVEL TARGETS FOR ANTIDEPRESSANTS
CONCLUSION
REFERENCES
Novel antihistamine drug JNJ 39758979
Introduction
H4 receptors
Experimental design for testing of efficacy of JNJ 39758979
Results
Adverse effects of JNJ 39758979
Comparison of affinity of antihistamines under study
Post Hoc comparison
Pharmacokinetics
Limitations of this test
Conclusion
Reference
THANK YOU
micro teaching on communication m.sc nursing.pdf
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Non-respiratory Functions of the Lungs.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
More Related Content
More from PHARMA IQ EDUCATION
UNIT- 10 ANIMAL CELL CULTURE TECHNIQUES (3).pptx
1. History of Cell Culture
2. Introduction to cell culture
3. types of cell lines
4. culture media
5. serum in culture media
6. Applications of cell & tissue culture
7. Adherence
8. Cell line evolution
9. Passaging, revival and cryopreservation
10. cell culture laboratory layout
LABORATORY SETUP OF A CELL CULTURE LAB
1. Typical setup of a cell culture lab
2. Cell culture equipment
3. Equipment & materials required
4. Basic components of a cell culture lab
5. Aseptic work area
6. Cell culture hood
7. Clean benches
8. Incubators
9. Storage
10. Cell counter
11. Aseptic techniques
12. Sterilization
13. References
Introduction to cell culture- concepts of cell culture part-1
Introduction to Cell Culture
What is Cell Culture?
Finite vs Continuous Cell Line
Culture Conditions
Cryopreservation
Morphology of Cells in Culture
Applications of Cell Culture
PORTAL HYPERTENSION
1. Introduction & history of portal hypertension
2. Etiology & pathophysiology of portal hypertension
3. Preclinical models of portal hypertension
4. Current, potential & future therapeutic approaches
5. Future prospects
6. References
Regulatory Affairs Interview Questions .pdf
This document contains the mostly asked questions for the job interviews of drug regulatory affairs which will help the candidate ace the interview with ease
Thank me later for this :*)
Hypersensitivity reactions
1. What are hypersensitivity reactions
2. Types of hypersensitivity reactions
3. Type 1 Hypersensitivity reaction
4. Type 2 Hypersensitivity reaction
5. Type 3 Hypersensitivity reaction
6. Type 4 Hypersensitivity reaction
7. Summary
EXPERIMENTAL MODELS OF LIVER DAMAGE
1. Introduction & Pathophysiology of Liver fibrosis
2. Experimental Models of Hepatic fibrosis
3. Timeline of development of Fibrotic models
4. Surgically developed models for Fibrosis
5. Chemically Induced Models for Fibrosis
6. Diet Induced Models for Fibrosis
7. Infection based models
8. Extra points
9. Conclusion
10. References
ANTIOXIDANTS FOR HEPATIC CIRRHOSIS.pptx
1. WHAT IS HEPATIC CIRRHOSIS
2. STAGES OF HEPATIC CIRRHOSIS
3. HEPATIC CIRRHOSIS ASSOCIATED COMORBIDITIES
4. PATHOPHYSIOLOGY OF HEPATIC CIRRHOSIS
5. MOLECULAR AND CELLULAR MECHANISMS INVOLVED IN LIVER FIBROGENESIS
6. FREE RADICALS
7. HOW DO FREE RADICALS CAUSE HEPATIC FIBROSIS/ CIRRHOSIS
8. POTENTIAL THERAPEUTIC COMPOUNDS BASED ON ANTIOXIDANT PROPERTIES
INFLAMMATORY BOWEL DISEASES
1. What are IBD
2. Causes of IBD
3. Signs/ symptoms & complications of IBD
4. Crohn's disease- pathophysiology
5. Ulcerative colitis- pathophysiology
6. Preclinical models for IBD
7. DSS induced IBD
8. Terminalia chebula extracts
GENE AND CELL THERAPY FOR CVDs
1. Gene therapy
2. Principles of gene therapy
3. Viral vectors of gene therapy
4. Non- viral vectors of gene therapy
5. Molecular Targets for gene therapy in CVDs
6. General strategies for gene therapy
7. Cell therapy for CVDs
8. Barriers for gene therapy
9. Routes of administration for gene therapy
10. Clinical trials
11. Conclusion
12. References
THANK YOU
GENE THERPY & CELL BASED THERAPY FOR CNS DISORDERS
1. WHAT IS GENE THERAPY
2. PRINCIPLE OF GENE THERAPY
3. TYPES OF GENE THERAPY
4. VECTORS IN GENE DELIVERY SYSTEM
5. ROLE OF GENE THERAPY IN CNS DISORDERS
6. GENE THERAPY FOR ALZHEIMERS DISEASE
7. GENE THERAPY FOR AMYOTROPIC LATERAL SCLEROSIS
8. GENE THERAPY FOR STROKE
9. CELL THERAPY FOR CNS DISORDERS
10. CELL THERAPY STRATEGIES
11. CELL THERAPY FOR PARKINSON
12. CELL THERAPY FOR HUNTINGTONS DISEASE
13. CRISPR/CAS9
NOVEL DRUG DELIVERY SYSTEMS- A FLASHCARD
1. DRUG RELEASE PROFILE IN CDDS
2. Drug release profile graph
3. CLASSIFICATION OF CONTROLLED RELEASE SYSTEMS
4. DIFFERENCES BETWEEN MATRIX & RESERVOIR SYSTEM
5. RETARDANTS USED IN MATRIX TABLET FORMULATION
6. CLASSIFICATION OF NOVEL DRUG DELIVERY SYSTEMS
7. FORMULATION OF TRANSDERMAL DRUG DELIVERY SYSTEMS
8. CLINICALLY APPROVED LIPOSOMAL FORMULATIONS
MULTIFACETED ROLES OF AUTOPHAGY IN CANCER & NEURODEGENERATIVE DISORDERS
1. What is Autophagy
2. Overview of the mechanisms lying behind autophagy
3. Mechanism of autophagy
4. Physiological role of autophagy
5. Role of Autophagy in cancer
6. Autophagy in tumor suppression
7. Autophagy in tumor promotion
8. Role of Autophagy in neurodegenerative diseases
9. Mechanism of autophagy in neurodegenerative disorders
10. Conclusion
11. References
12. Thank You
Biotransformation
1. Introduction
2. Phase 1 metabolism- Oxidation, reduction, conjugation, hydrolysis
3. Phase 2 metabolism- glucuronidation, sulfonation, acetylation, methylation, glycination, glutathionation, ribonucleotide based metabolism
4. Summary
5. Thank you
Sulphate Conjugation & EMT pathways in cancer
1. Sulphonation metabolism- introduction, types of sulphate transferases, reactions, summary
2. EMT pathways explaining metastasis in cancer and molecular pathways
3. Thank you
The pharmacology of anti-depressants
WHAT IS DEPRESSION
ETIOLOGY OF DEPRESSION
HISTORY, EXAMINATION & EPIDEMIOLOGY OF DEPRESSION
PATHOPHYSIOLOGY
ANTI- DEPRESSANTS
MAO- INHIBITORS
TCA ANTIDEPRESSANTS
SSRI’s
SNRI’s
ATYPICAL ANTIDEPRESSANTS
NOVEL TARGETS FOR ANTIDEPRESSANTS
CONCLUSION
REFERENCES
Novel antihistamine drug JNJ 39758979
Introduction
H4 receptors
Experimental design for testing of efficacy of JNJ 39758979
Results
Adverse effects of JNJ 39758979
Comparison of affinity of antihistamines under study
Post Hoc comparison
Pharmacokinetics
Limitations of this test
Conclusion
Reference
THANK YOU
More from PHARMA IQ EDUCATION (20)
Introduction to cell culture- concepts of cell culture part-1
Introduction to cell culture- concepts of cell culture part-1
GENE THERPY & CELL BASED THERAPY FOR CNS DISORDERS
GENE THERPY & CELL BASED THERAPY FOR CNS DISORDERS
MULTIFACETED ROLES OF AUTOPHAGY IN CANCER & NEURODEGENERATIVE DISORDERS
MULTIFACETED ROLES OF AUTOPHAGY IN CANCER & NEURODEGENERATIVE DISORDERS
Recently uploaded
micro teaching on communication m.sc nursing.pdf
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Non-respiratory Functions of the Lungs.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Physiology of Chemical Sensation of smell.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
PPT RELATED TO ARTHROLOGY ACCORDING TO NCISM AYURVEDA
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Prix Galien International 2024 Forum Program
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Valuable Content of Human Anatomy and Physiology of Urinary system as per PCI Syllabus for Pharmacy and PharmD Students.
Physiology of Special Chemical Sensation of Taste
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With 100% Satisfaction
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Recently uploaded (20)
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls